Cancer center launches new science hub called WeCARE
By Stephanie Winn
Goal is to bring research equity to detection and treatment of breast and gynecologic cancers
(SACRAMENTO)
UC Davis Comprehensive Cancer Center has created a new hub to share scientific findings with the public as well as among researchers and clinicians to drive innovative, multi-disciplinary advancements in the prevention and treatment of breast cancer and gynecologic cancers.
The Women’s Cancer Care and Research Program (WeCARE) is committed to community-informed science that will foster dialogue and promote health equity and diversity. The goal is to fuel clinical research and trial development to benefit people with breast and gynecologic cancers (ovarian, cervical, uterine, vaginal and vulvar).
“We want to enhance our portfolio of team-based, community-engaged and multidisciplinary research in breast and gynecologic cancers at UC Davis,” said Laura Fejerman, one of the directors of WeCARE and associate director of the cancer center’s Office of Community Outreach and Engagement.
We appreciate the backing of the cancer center to provide seed funding that will grow innovative multidisciplinary science to advance breast and gynecologic cancer equity.”—Laura Fejerman
WeCARE will facilitate and support the development of prevention and early detection programs, care innovation and research for breast and gynecologic cancers. The program will leverage innovative and multidisciplinary approaches to reduce the cancer burden and achieve health equity.
“We appreciate the backing of the cancer center to provide $50,000 in seed funding that will grow innovative multidisciplinary science to advance breast and gynecologic cancer equity,” Fejerman said.
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 100,000 adults and children every year and access to more than 200 active clinical trials at any given time. Its innovative research program engages more than 240 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Office of Community Outreach and Engagement addresses disparities in cancer outcomes across diverse populations, and the cancer center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists. For more information, visit cancer.ucdavis.edu.
